Save your seat for this upcoming webinar! Are CROs more efficient at study startup - a notorious bottleneck in clinical trials?
Title: Outsourcing to CROs - Grand Experiment or Logical Success?
Over the last several decades as the size, complexity, length, cost and globalization of clinical trials has continued to grow, the importance of contract research organizations (CROs) to the pharmaceutical industry has increased significantly. Outsourcing has become a popular way for pharmaceutical companies to utilize on-demand services to improve operational efficiency and therapeutic expertise, cut costs, and add more extensive geographic capabilities.
Technology investments are catalyzing the study startup process - an entrenched bottleneck in study conduct - with more investment coming in from CROs.
More than just a fad, this trend is nothing less than a paradigm shift in the pharmaceutical industry that has struggled to contain costs and timelines associated with trials as the rescue study services industry has boomed. But are CROs more efficient at study startup?
- The comparison of average overall cycle times (repeat vs. new sites) of CROs vs. Sponsors
- Comparisons of satisfaction levels and technology investment across all stages of study startup
- Technology adequacy and savings reported due to technology deployment
- A discussion on opportunities for improvement in study startup by organization
Tuesday, June 26
1 pm ET
10 am PT
Clinical Performance Partners
Beth is the President of Clinical Performance Partners, Inc., a clinical research consulting firm specializing in enrollment and site performance management and facilitating productive sponsor-site relationships. Beth leverages her 30 years of site, SMO, CRO, Pharma, Consulting, Training and Service Provider experiences, both domestically and internationally, to identify solutions for optimizing the clinical trials process.
Senior Strategic Advisor
As the Senior Strategic Advisor, Joan is responsible for providing strategic guidance and direction to companies and professionals to further build their presence in the clinical trials enterprise.
A well-known speaker at industry conferences and symposiums, Joan has presented on a wide variety of topics specific to the clinical trials enterprise. In the course of her career, she has also published in clinical trade journals. For five years, she was an instructor for Barnett International's CRA/CRC programs on the site identification/qualification process. Joan is on the Bridging Collaborative Advisory Committee, Board of Directors for Greater Gift, The Center for Information and Study on Clinical Research Participation (CISCRP), the US PharmaTimes Steering Committee for CROY, the Steering Committee for Pharma Intelligence/Informa Clinical & Research Excellence Awards, Advisory Board for BioBridges, and is an active member of the Association of Clinical Research Professionals (ACRP) and the Drug Information Association (DIA).
Prior to joining SCORR Marketing in November 2017, Joan spent over seven and a half years with CenterWatch as COO, two and a half years with Cambridge Healthtech Institute as Senior Director of Marketing & Operations-Publications; two and a half years with the Tufts Center for the Study of Drug Development at Tufts University as Director of Strategic Marketing & Development; seven and a half years with Thomson CenterWatch as Senior Director of Marketing & Sales; and four years working for PAREXEL International as Site Selection Specialist. Joan holds a B.S. in Marketing.
Rob has been a computer scientist and programmer for over 30 years in the scientific programming, e-commerce, biotech, and health care industries. He implemented study startup and CTMS functionality at 9 bay area biotech companies and invented a method that allows medical and biotech organizations to use cloud-based analytics to monitor patient data. He holds a BS in Computer Engineering from Sacramento State University and a PhD in Biological and Biomedical Clinical Informatics from UCSF.